Panakeia has been included in the finalist list for the OBN Awards 2022

pahini5
Sep 15, 2022
1 min read

We are delighted to share that Panakeia has been included in the finalist list for the OBN Awards 2022 in the Best Emerging Medtech Company category. Congratulation to all the other nominees and good luck to everyone for the finals at the #OBNAwards, on Thursday 17th November at the Royal Lancaster London. Read more...

Panakeia to attend and present at upcoming scientific and business conferences

Cambridge, UK, 9 April 2025 – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm...

Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium

Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancer

PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...